Title:
AGENT FOR TREATING INFLAMMATORY BOWEL DISEASE, AND AMIDE COMPOUND OR SALT THEREOF
Document Type and Number:
WIPO Patent Application WO/2021/201120
Kind Code:
A1
Abstract:
An agent for treating inflammatory bowel disease that comprises an amide compound represented by formula (I-1) or a salt thereof, and an amide compound represented by formula (III) or a salt thereof. In the formulae: R1 to R4 each independently represent a hydrogen atom or a substituent, provided that all of R1 to R4 do not represent hydrogen atoms at the same time, or R1 to R4 may be bonded together to form an optionally substituted aromatic hydrocarbon ring or an optionally substituted aromatic heterocycle; at least one of R5s represents a fluorine atom; RA1 represents an optionally substituted C1-10 alkyl group or an optionally substituted C3-6 cycloalkyl group; and RA2 represents a hydrogen atom, an optionally substituted C1-10 alkyl group or an optionally substituted C3-6 cycloalkyl group.
More Like This:
| JP2005504051 | New sustained-release oral preparation |
| WO/2000/040225 | INHIBITION OF TNF ACTIVITY |
| JP5492092 | Compounds that regulate CB2 receptors |
Inventors:
HASE KOJI (JP)
TAKAHASHI DAISUKE (JP)
SUZUKI TAKAYOSHI (JP)
KUROHARA TAKASHI (JP)
UEDA SATOSHI (JP)
TANAKA KEITA (JP)
TAKAHASHI DAISUKE (JP)
SUZUKI TAKAYOSHI (JP)
KUROHARA TAKASHI (JP)
UEDA SATOSHI (JP)
TANAKA KEITA (JP)
Application Number:
PCT/JP2021/013899
Publication Date:
October 07, 2021
Filing Date:
March 31, 2021
Export Citation:
Assignee:
UNIV KEIO (JP)
UNIV OSAKA (JP)
FUJIFILM CORP (JP)
UNIV OSAKA (JP)
FUJIFILM CORP (JP)
International Classes:
A61P1/00; A61K31/4035; A61K31/4045; A61K31/405; A61K31/4155; A61K31/4439; A61K31/497; C07D209/44; C07D401/12; C07D401/14; C07D403/12; C07D487/04; C07D495/04
Domestic Patent References:
| WO2017095758A1 | 2017-06-08 | |||
| WO2010038465A1 | 2010-04-08 | |||
| WO2012174199A1 | 2012-12-20 |
Foreign References:
| JP2015500845A | 2015-01-08 |
Attorney, Agent or Firm:
TAIYO, NAKAJIMA & KATO (JP)
Download PDF: